FindTrial
Sign In

Outcome of Transcatheter Closure of Patent Ductus Arteriosus in Pediatric Cardiology Unit in 3 Years Duration

Transcatheter Closure of Patent Ductus Arteriosus. Experience of Pediatric Cardiology Unit-Assiut University Hospital

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06634407
Enrollment
90
Registered
2024-10-09
Start date
2024-10-25
Completion date
2025-09-15
Last updated
2024-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patent Ductus Arteriosus (PDA)

Brief summary

Transcatheter Closure of Patent Ductus Arteriosus to evaluate the outcome of percutaneous transcatheter closure of patent ductus arteriosus in children

Interventions

PROCEDUREtranscatheter closure

using transcatheter closure of PDA to detect outcome of patients with PDA

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children with Patent Ductus Arteriosus confirmed by echocardiography * aged from 6 months to 16 years underwent percutaneous transcatheter PDA closure at Pediatric Cardiology Unit.

Exclusion criteria

* Children with PDA younger than 6 months or older than 16 years and that are not candidate for transcatheter closure .

Design outcomes

Primary

MeasureTime frameDescription
outcome of trancathter PDA closure3 yearsoutcome of 90 patients with trancatheter PDA closure in pediatrics using post procedure catheter and echocardiography

Contacts

Primary ContactBassem Eldaba Fares bassem fares
basam.13298661@med.aun.edu.eg+201220851469

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026